KYXINKO Trademark

Trademark Overview


On Friday, November 6, 2020, a trademark application was filed for KYXINKO with the United States Patent and Trademark Office. The USPTO has given the KYXINKO trademark a serial number of 79300480. The federal status of this trademark filing is REGISTERED as of Tuesday, September 20, 2022. This trademark is owned by LABORATORIOS FARMACEUTICOS ROVI, S.A.. The KYXINKO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, antibiotics, analgesics, anesthetics for surgical and non-surgical use, amino acids for medical use, antiseptics, tranquilizers, collyriums, digestives for pharmaceutical purposes, laxatives, prescription synthetic narcotics; chemical products for medical use, namely, pharmaceuticals for treating schizophrenia; chemical pharmaceuticals preparations for the treatment of central nervous system diseases; medicines for the treatment of headache in the form of tonics; tranquillizers; soporifics; antipsychotics; medicated serums for the treatment of eczema; hormones; contraceptive preparations; vaccines, syringes, vials, cartridges or carpules and ampoules for medical purposes, all sold pre-filled with pharmaceutical preparations in the nature of antipsychotics; implantable subcutaneous pharmaceutical delivery devices sold pre-filled with insulin; implantable drug delivery devices sold pre-filled with contraceptives; Pharmaceuticals, namely, oncological prepa...
kyxinko

General Information


Serial Number79300480
Word MarkKYXINKO
Filing DateFriday, November 6, 2020
Status700 - REGISTERED
Status DateTuesday, September 20, 2022
Registration Number6848725
Registration DateTuesday, September 20, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2022

Trademark Statements


Goods and ServicesPharmaceutical products, namely, antibiotics, analgesics, anesthetics for surgical and non-surgical use, amino acids for medical use, antiseptics, tranquilizers, collyriums, digestives for pharmaceutical purposes, laxatives, prescription synthetic narcotics; chemical products for medical use, namely, pharmaceuticals for treating schizophrenia; chemical pharmaceuticals preparations for the treatment of central nervous system diseases; medicines for the treatment of headache in the form of tonics; tranquillizers; soporifics; antipsychotics; medicated serums for the treatment of eczema; hormones; contraceptive preparations; vaccines, syringes, vials, cartridges or carpules and ampoules for medical purposes, all sold pre-filled with pharmaceutical preparations in the nature of antipsychotics; implantable subcutaneous pharmaceutical delivery devices sold pre-filled with insulin; implantable drug delivery devices sold pre-filled with contraceptives; Pharmaceuticals, namely, oncological preparations for the treatment of cancer; preparations for the treatment of diseases of the central nervous system; preparations for the treatment of schizophrenia; preparations for the treatment of hormonal disorders; preparations for the treatment of allergies, for disorders of the skin, thrombosis, coagulation diseases, infections, flu, pain and inflammation; tranquilizers, prescription synthetic narcotics, antidepressants, anxiolytics; chemical pharmaceuticals for the treatment of diseases of the central nervous system; disposable syringes sold pre-filled with pharmaceutical preparations for treatment of central nervous system diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLABORATORIOS FARMACEUTICOS ROVI, S.A.
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressES

Party NameLABORATORIOS FARMACEUTICOS ROVI, S.A.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressES

Party NameLABORATORIOS FARMACEUTICOS ROVI, S.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressES

Trademark Events


Event DateEvent Description
Sunday, January 15, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, December 22, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, December 22, 2022FINAL DISPOSITION PROCESSED
Tuesday, December 20, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 20, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 20, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 5, 2022NOTIFICATION PROCESSED BY IB
Tuesday, July 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 15, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 15, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 15, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, June 12, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Monday, May 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 30, 2022EXAMINER'S AMENDMENT ENTERED
Monday, May 30, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 30, 2022EXAMINERS AMENDMENT E-MAILED
Monday, May 30, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 25, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 25, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, May 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, March 13, 2022REFUSAL PROCESSED BY IB
Thursday, February 24, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 24, 2022REFUSAL PROCESSED BY MPU
Saturday, January 29, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 28, 2022NON-FINAL ACTION WRITTEN
Saturday, January 22, 2022ASSIGNED TO EXAMINER
Friday, January 15, 2021APPLICATION FILING RECEIPT MAILED
Monday, January 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 7, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 24, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB